ID NOS1_SHEEP Reviewed; 1463 AA. AC Q29498; P79210; W5P268; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 08-NOV-2023, sequence version 3. DT 27-MAR-2024, entry version 142. DE RecName: Full=Nitric oxide synthase 1 {ECO:0000305}; DE EC=1.14.13.39 {ECO:0000250|UniProtKB:P29476}; DE AltName: Full=Constitutive NOS; DE AltName: Full=NC-NOS; DE AltName: Full=NOS type I; DE AltName: Full=Neuronal NOS; DE Short=N-NOS; DE Short=NNOS; DE AltName: Full=Nitric oxide synthase, brain {ECO:0000305}; DE Short=bNOS {ECO:0000305}; DE AltName: Full=Peptidyl-cysteine S-nitrosylase NOS1; GN Name=NOS1; OS Ovis aries (Sheep). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Caprinae; Ovis. OX NCBI_TaxID=9940; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Texel; RX PubMed=20809919; DOI=10.1111/j.1365-2052.2010.02100.x; RA Archibald A.L., Cockett N.E., Dalrymple B.P., Faraut T., Kijas J.W., RA Maddox J.F., McEwan J.C., Hutton Oddy V., Raadsma H.W., Wade C., Wang J., RA Wang W., Xun X.; RT "The sheep genome reference sequence: a work in progress."; RL Anim. Genet. 41:449-453(2010). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 49-121. RA Mimmack M.L.; RL Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1020-1132. RC TISSUE=Neuron; RA Aguan K., Weiner C.P.; RT "Effect of hypoxia on the expression pattern of neuronal nitric oxide RT synthase gene in the sheep fetal brain microvasculature."; RL Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with CC diverse functions throughout the body. In the brain and peripheral CC nervous system, NO displays many properties of a neurotransmitter. CC Probably has nitrosylase activity and mediates cysteine S-nitrosylation CC of cytoplasmic target proteins such SRR (By similarity). CC {ECO:0000250|UniProtKB:P29476}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+) + 2 L-arginine + 3 NADPH + 4 O2 = 4 H2O + 2 L-citrulline CC + 3 NADP(+) + 2 nitric oxide; Xref=Rhea:RHEA:19897, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16480, ChEBI:CHEBI:32682, ChEBI:CHEBI:57743, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.39; CC Evidence={ECO:0000250|UniProtKB:P29476}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19898; CC Evidence={ECO:0000250|UniProtKB:P29476}; CC -!- COFACTOR: CC Name=heme b; Xref=ChEBI:CHEBI:60344; CC Evidence={ECO:0000250|UniProtKB:P29475}; CC -!- COFACTOR: CC Name=FAD; Xref=ChEBI:CHEBI:57692; CC Evidence={ECO:0000250|UniProtKB:P29476}; CC Note=Binds 1 FAD. {ECO:0000250|UniProtKB:P29476}; CC -!- COFACTOR: CC Name=FMN; Xref=ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:P29476}; CC Note=Binds 1 FMN. {ECO:0000250|UniProtKB:P29476}; CC -!- COFACTOR: CC Name=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin; CC Xref=ChEBI:CHEBI:59560; Evidence={ECO:0000250|UniProtKB:P29475}; CC Note=Tetrahydrobiopterin (BH4). May stabilize the dimeric form of the CC enzyme. {ECO:0000250|UniProtKB:P29475}; CC -!- ACTIVITY REGULATION: Stimulated by calcium/calmodulin. Inhibited by CC DYNLL1 that prevents the dimerization of the protein. Inhibited by CC NOSIP. {ECO:0000250|UniProtKB:P29476}. CC -!- SUBUNIT: Homodimer. Interacts with DLG4; the interaction possibly being CC prevented by the association between NOS1 and CAPON. Forms a ternary CC complex with CAPON and RASD1. Forms a ternary complex with CAPON and CC SYN1. Interacts with ZDHHC23. Interacts with NOSIP; which may impair CC its synaptic location (By similarity). Interacts with HTR4 (By CC similarity). Interacts with SLC6A4. Interacts with VAC14 (By CC similarity). Interacts (via N-terminal domain) with DLG4 (via N- CC terminal tandem pair of PDZ domains). Interacts with SLC6A4. Forms a CC complex with ASL, ASS1 and SLC7A1; the complex regulates cell- CC autonomous L-arginine synthesis and citrulline recycling while CC channeling extracellular L-arginine to nitric oxide synthesis pathway CC (By similarity). Interacts with DMD; localizes NOS1 to sarcolemma in CC muscle cells (By similarity). Interacts with DYNLL1; inhibits the CC nitric oxide synthase activity (By similarity). CC {ECO:0000250|UniProtKB:P29476, ECO:0000250|UniProtKB:Q9Z0J4}. CC -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma CC {ECO:0000250|UniProtKB:Q9Z0J4}; Peripheral membrane protein CC {ECO:0000255}. Cell projection, dendritic spine CC {ECO:0000250|UniProtKB:P29476}. Note=In skeletal muscle, it is CC localized beneath the sarcolemma of fast-twitch muscle fiber by CC associating with the dystrophin glycoprotein complex (By similarity). CC In neurons, enriched in dendritic spines (By similarity). CC {ECO:0000250|UniProtKB:P29476, ECO:0000250|UniProtKB:Q9Z0J4}. CC -!- DOMAIN: The PDZ domain participates in protein-protein interaction, and CC is responsible for targeting nNos to synaptic membranes. Mediates CC interaction with VAC14. {ECO:0000250|UniProtKB:P29476}. CC -!- PTM: Ubiquitinated; mediated by STUB1/CHIP in the presence of Hsp70 and CC Hsp40 (in vitro). {ECO:0000250|UniProtKB:P29476}. CC -!- SIMILARITY: Belongs to the NOS family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AMGL01039383; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AMGL01039384; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; X99042; CAA67503.1; -; Genomic_DNA. DR EMBL; U76739; AAB40706.1; -; mRNA. DR AlphaFoldDB; Q29498; -. DR SMR; Q29498; -. DR STRING; 9940.ENSOARP00000004517; -. DR PaxDb; 9940-ENSOARP00000004517; -. DR Ensembl; ENSOART00000004598.1; ENSOARP00000004517.1; ENSOARG00000004210.1. DR eggNOG; KOG1158; Eukaryota. DR OMA; KCPEPLR; -. DR Proteomes; UP000002356; Chromosome 17. DR Bgee; ENSOARG00000004210; Expressed in major salivary gland and 26 other cell types or tissues. DR ExpressionAtlas; Q29498; baseline. DR GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell. DR GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell. DR GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW. DR GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro. DR GO; GO:0010181; F:FMN binding; IEA:InterPro. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0050661; F:NADP binding; IEA:InterPro. DR GO; GO:0004517; F:nitric-oxide synthase activity; ISS:UniProtKB. DR GO; GO:0006809; P:nitric oxide biosynthetic process; IEA:InterPro. DR CDD; cd06202; Nitric_oxide_synthase; 1. DR CDD; cd00795; NOS_oxygenase_euk; 1. DR CDD; cd00992; PDZ_signaling; 1. DR Gene3D; 2.30.42.10; -; 1. DR Gene3D; 3.40.50.360; -; 1. DR Gene3D; 3.90.440.10; Nitric Oxide Synthase;Heme Domain;Chain A domain 2; 1. DR Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1. DR Gene3D; 2.40.30.10; Translation factors; 1. DR InterPro; IPR003097; CysJ-like_FAD-binding. DR InterPro; IPR017927; FAD-bd_FR_type. DR InterPro; IPR001094; Flavdoxin-like. DR InterPro; IPR008254; Flavodoxin/NO_synth. DR InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase. DR InterPro; IPR029039; Flavoprotein-like_sf. DR InterPro; IPR039261; FNR_nucleotide-bd. DR InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha. DR InterPro; IPR044943; NOS_dom_1. DR InterPro; IPR044940; NOS_dom_2. DR InterPro; IPR044944; NOS_dom_3. DR InterPro; IPR012144; NOS_euk. DR InterPro; IPR004030; NOS_N. DR InterPro; IPR036119; NOS_N_sf. DR InterPro; IPR001433; OxRdtase_FAD/NAD-bd. DR InterPro; IPR001478; PDZ. DR InterPro; IPR036034; PDZ_sf. DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl. DR PANTHER; PTHR43410; NITRIC OXIDE SYNTHASE OXYGENASE; 1. DR PANTHER; PTHR43410:SF1; NITRIC OXIDE SYNTHASE OXYGENASE; 1. DR Pfam; PF00667; FAD_binding_1; 1. DR Pfam; PF00258; Flavodoxin_1; 1. DR Pfam; PF00175; NAD_binding_1; 1. DR Pfam; PF02898; NO_synthase; 1. DR Pfam; PF00595; PDZ; 1. DR PIRSF; PIRSF000333; NOS; 1. DR PRINTS; PR00369; FLAVODOXIN. DR PRINTS; PR00371; FPNCR. DR SMART; SM00228; PDZ; 1. DR SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1. DR SUPFAM; SSF52218; Flavoproteins; 1. DR SUPFAM; SSF56512; Nitric oxide (NO) synthase oxygenase domain; 1. DR SUPFAM; SSF50156; PDZ domain-like; 1. DR SUPFAM; SSF63380; Riboflavin synthase domain-like; 1. DR PROSITE; PS51384; FAD_FR; 1. DR PROSITE; PS50902; FLAVODOXIN_LIKE; 1. DR PROSITE; PS60001; NOS; 1. DR PROSITE; PS50106; PDZ; 1. PE 2: Evidence at transcript level; KW Calmodulin-binding; Cell membrane; Cell projection; FAD; Flavoprotein; FMN; KW Heme; Iron; Membrane; Metal-binding; NADP; Oxidoreductase; Phosphoprotein; KW Reference proteome; Synapse; Ubl conjugation. FT CHAIN 1..1463 FT /note="Nitric oxide synthase 1" FT /id="PRO_0000170925" FT DOMAIN 17..99 FT /note="PDZ" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00143" FT DOMAIN 755..969 FT /note="Flavodoxin-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00088" FT DOMAIN 1024..1271 FT /note="FAD-binding FR-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00716" FT REGION 1..200 FT /note="Interaction with NOSIP" FT /evidence="ECO:0000250|UniProtKB:P29476" FT REGION 110..194 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 158..240 FT /note="DYNLL1/PIN/nNOS-inhibiting protein-binding" FT /evidence="ECO:0000250|UniProtKB:P29476" FT REGION 215..250 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 268..298 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 725..745 FT /note="Calmodulin-binding" FT /evidence="ECO:0000250|UniProtKB:P29476" FT COMPBIAS 229..249 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 272..294 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 334 FT /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin" FT /ligand_id="ChEBI:CHEBI:59560" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 415 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 478 FT /ligand="L-arginine" FT /ligand_id="ChEBI:CHEBI:32682" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 587 FT /ligand="L-arginine" FT /ligand_id="ChEBI:CHEBI:32682" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 588 FT /ligand="L-arginine" FT /ligand_id="ChEBI:CHEBI:32682" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 592 FT /ligand="L-arginine" FT /ligand_id="ChEBI:CHEBI:32682" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 677 FT /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin" FT /ligand_id="ChEBI:CHEBI:59560" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 678 FT /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin" FT /ligand_id="ChEBI:CHEBI:59560" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 691 FT /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin" FT /ligand_id="ChEBI:CHEBI:59560" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 706 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000250|UniProtKB:P29475" FT BINDING 761 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 762 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 763 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 765 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 766 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 807 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 808 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 812 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 920 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 925 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 927 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 953 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 957 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1044 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1066 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1207 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1208 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1209 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1210 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1225 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1227 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1230 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1231 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1244 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1245 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1246 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1285 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1318 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1347 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1348 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1354 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1356 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1358 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1391 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1432 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT BINDING 1434 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P29476" FT MOD_RES 881 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P29476" FT MOD_RES 891 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9Z0J4" FT MOD_RES 892 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P29476" FT CONFLICT 84 FT /note="L -> F (in Ref. 2; CAA67503)" FT /evidence="ECO:0000305" FT CONFLICT 121 FT /note="R -> H (in Ref. 2; CAA67503)" FT /evidence="ECO:0000305" SQ SEQUENCE 1463 AA; 164011 MW; D781502A207161A1 CRC64; MESHMFSVQQ IQPNVISVRL FKRKVGGLGF LVKERVSKPP VIISDLIRGG AAEQSGLIQA GDIILAVNGQ PLVDLSYDSA LEVLRGIASE THVVLILRGP EGFTTHLETT FTGDGTPKTI RVTRPGRVTP PPDAPAGREQ PRAVDGAPGP GNGPQHAPDP GQEASSLAQA NGLAARPPGQ DPAKKSTGVA LQGSGENNKL LKEIEPVLNL LTSGGKAING GGPAKTETKD VEVQVDRDPD SKSHKPLPLG VENDRVFNDL WGKGNMPVVL NNPYSEKEQP SASGKQSPTK NGSPSKCPRF LKVKNWETDV VLSDTLHLKS TLGTGCTEHI CMGSVMLPSQ QIRKPEDVRT KEQLFPLAKE FIDQYYSSIK RFGSKAHMER LEEVNKEIET TSTYQLKDTE LIYGAKHAWR NASRCVGRIQ WSKLQVFDAR DCTTAHGMFN YICNHIKYAT NKGNLRSAIT IFPQRTDGKH DFRVWNSQLI RYAGYKQPDG SILGDPANVE FTEICIQQGW KPPRSRFDVL PLLLQANGND PELFQIPPEL VLEVPIRHPK FEWFKDLGLK WYGLPAVSNM LLEIGGLEFS ACPFSGWYMG TEIGVRDYCD SSRYNILEDV AKKMNLDMRK TSSLWKDQAL VEINIAVLYS FQSDKVTIVD HHSATESFIK HMENEYRCRG GCPADWVWIV PPMSGSITPV FHQEMLNYRL TPSFEYQPDP WNTHVWKGTN GTPTKRRAIG FKKLAEAVKF SAKLMGQAMA KRVKATILYA TETGKSQAYA KTLCEIFKHA FDAKVMSMEE YDIVHLEHET LVLVVTSTFG NGDPPENGEK FGCALMEMRN PNSVHEERKY PEPLRFFPRK GPPLSRGDTE VHGLAAVRDS QLRSYKVRFN SVSSYSDSRK SSGDGPDLRD NFESTGPLAN VRFSVFGLGS RAYPHFCAFG HAVDTLLEEL GGERILKMRE GDELCGQEEA FRTWAKKVFK AACDVFCVGD DVNIEKANNS LISNDRSWKR NKFRLTYVAE APELTQGLSN VHKKRVSAAR LLSRQNLQSP KSSRSTIFVR LHTNGNQELQ YQPGDHLGVF PGNHEDLVNA LIERLEDAPP ANQLVKVELL EERNTALGVI SNWTDEHRLP PCTIFQAFKY YLDITTPPTP LQLQQFASLA TSEKERQRLL VLSKGLQEYE EWKWGKNPTI VEVLEEFPSI QMPSTLLLTQ LSLLQPRYYS ISSSPDMYPD EVHLTVAIVS YRTRDGEGPI HHGVCSSWLN RIQADEVVPC FVRGAPSFHL PQNPQVPCIL VGPGTGIAPF RSFWQQRQFD IQHKGMSPCP MVLVFGCRQS KIDHIYREEA LQAKSKGVFR ELYTAYSREP DKPKKYVQDI LQEQLAEPVY RALKEQGGHI YVCGDVTMAA DVLKAIQRIM TQKGKLSVED AGVFISRLRD DNRYHEDIFG VTLRTYEVTN RLRSESIAFI EESKKDTDEV FSS //